Form 8-K - Current report:
SEC Accession No. 0000950170-25-027947
Filing Date
2025-02-26
Accepted
2025-02-26 17:21:12
Documents
14
Period of Report
2025-02-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agen-20250220.htm   iXBRL 8-K 52708
2 EX-4.1 agen-ex4_1.htm EX-4.1 146724
3 EX-4.2 agen-ex4_2.htm EX-4.2 153642
4 EX-4.3 agen-ex4_3.htm EX-4.3 146380
  Complete submission text file 0000950170-25-027947.txt   677070

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20250220.xsd EX-101.SCH 23893
16 EXTRACTED XBRL INSTANCE DOCUMENT agen-20250220_htm.xml XML 4505
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 25671479
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)